Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study-Reference-Cited by-同舟云学术

Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study

Published:2021-06 Issue:6 Volume:22 Page:813-823
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

van den Bent Martin J,Tesileanu C Mircea S,Wick Wolfgang,Sanson Marc,Brandes Alba Ariela,Clement Paul M,Erridge Sarah,Vogelbaum Michael A,Nowak Anna K,Baurain Jean Français,Mason Warren P,Wheeler Helen,Chinot Olivier L,Gill Sanjeev,Griffin Matthew,Rogers Leland,Taal Walter,Rudà Roberta,Weller Michael,McBain Catherine,Reijneveld Jaap,Enting Roelien H,Caparrotti Francesca,Lesimple Thierry,Clenton Susan,Gijtenbeek Anja,Lim Elizabeth,Herrlinger Ulrich,Hau Peter,Dhermain Frederic,de Heer Iris,Aldape Kenneth,Jenkins Robert B,Dubbink Hendrikus Jan,Kros Johan M,Wesseling Pieter,Nuyens Sarah,Golfinopoulos Vassilis,Gorlia Thierry,French Pim,Baumert Brigitta G

Funder

The Brain Tumor Charity

Dutch Cancer Society

Publisher

Elsevier BV

Subject

Oncology

Reference30 articles.

1. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma;Stupp;N Engl J Med,2005

2. Adjuvant PCV improves progression free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized EORTC phase III trial;van den Bent;J Clin Oncol,2006

3. Phase III trial of chemotherapy plus radiotherapy (RT) versus RT alone for pure and mixed anaplastic oligodendroglioma (RTOG 9402): an intergroup trial by the RTOG, NCCTG, SWOG, NCI CTG and ECOG;Cairncross;J Clin Oncol,2006

4. Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study;van den Bent;Lancet,2017

5. An integrated genomic analysis of human glioblastoma multiforme;Parsons;Science,2008

Cited by 188 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in the treatment of IDH-mutant gliomas;Current Opinion in Neurology;2024-09-12

2. Vorasidenib: a new hope or a false promise for patients with low-grade glioma?;Nature Reviews Clinical Oncology;2024-09-12

3. Cancer therapy–related salivary dysfunction;Journal of Clinical Investigation;2024-09-03

4. Enhanced treatment of breast cancer brain metastases with oncolytic virus expressing anti-CD47 antibody and temozolomide;Molecular Therapy: Oncology;2024-09

5. Brain macrophage senescence in glioma;Seminars in Cancer Biology;2024-09